Liver cancer is the fifth most common cancer and the second leading cause of malignant
death in Asia, and Asia reports 72.5% of the world's cases in 2020. As the most common …

Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a new
inclusive definition of the whole spectrum of liver diseases associated to metabolic …

Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death.
Although the burden of alcohol-and NASH-related HCC is growing, chronic viral hepatitis …

The number of effective systemic therapies for the treatment of advanced hepatocellular
carcinoma (HCC) is rapidly increasing, and the advent of immunotherapy has changed the …

Non-alcoholic fatty liver disease (NAFLD) is defined as a chronic liver disease characterized
by excessive fat accumulation in the liver without another obvious cause (no excessive …

Objective We conducted the first meta-analysis to identify the predictive significance of
baseline blood biomarkers (such as neutrophil to lymphocyte ratio (NLR), early alpha …

Background and Aims Autoimmune hepatitis (AIH) is a rare chronic liver disease of unknown
aetiology; the risk of hepatocellular carcinoma (HCC) remains unclear and risk factors are …

Objective We aim to evaluate the relationship between the use of metformin and the risk of
pancreatic cancer in type 2 diabetes patients. Method We systematically searched the …

The pathogenesis of hepatocellular carcinoma (HCC) is a multifactorial process that has not
yet been fully investigated. Autophagy and apoptosis are two important cellular pathways …